Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.220
+0.040 (1.83%)
At close: Nov 20, 2024, 4:00 PM
2.266
+0.046 (2.08%)
After-hours: Nov 20, 2024, 5:09 PM EST
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $252.85 million as of November 21, 2024. Its market cap has increased by 11.04% in one year.
Market Cap
252.85M
Enterprise Value
54.90M
1-Year Change
11.04%
Ranking
Category
Stock Price
$2.22
Market Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $252.85M, an increase of 100.51%. That is a compound annual growth rate of 6.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 252.80M | -31.45% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroPace | 267.14M |
| Ocugen | 265.45M |
| Mersana Therapeutics | 260.65M |
| Poseida Therapeutics | 260.23M |
| Eton Pharmaceuticals | 259.14M |
| Neurogene | 257.53M |
| Abeona Therapeutics | 255.24M |
| Artiva Biotherapeutics | 250.42M |